Author

I. Teino

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

M. Karelson· 2 shared M. Saarma· 2 shared D. Blokhina· 1 shared E. Kankuri· 1 shared I. Ilves· 1 shared J. Harro· 1 shared K. Herodes· 1 shared K. Laugus· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

M. Karelson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Effect of RNA m6A methyltransferase activation by a low molecular weight compound on anxiety- and depression-related behaviours, monoamine neurochemistry and striatal gene expression in the rat

M. Kanarik, K. Liiver, M. Skolnaja, I. Teino, T. Org, K. Laugus, R. Shimmo, M. Karelson, M. Saarma, J. Harro

This study examines the effects of CHMA1004, a METTL3/METTL14 activator, on anxiety, depression, and striatal gene expression in rats, finding increased locomotor activity and anxiolytic-like effects.

bioRxiv · Jan 8, 2024 · PreprintPharmacology & Toxicology

Novel RNA m6A methyltransferase METTL16 inhibitors

S. Selberg, L. Ivanova, M. Kotli, K. Herodes, D. Blokhina, E. Kankuri, N. Seli, I. Ilves, I. Teino, M. Saarma, M. Karelson

This study identifies two nanomolar METTL16 inhibitors that reduce leukemia cell viability and m6A levels in HL-60 cells.

bioRxiv · Mar 27, 2023 · PreprintPharmacology & Toxicology